Epizyme ( EPZM +0.6%) and Roche's ( OTCQX:RHHBY ) Genentech will collaborate on a Phase 1b clinical trial to evaluate the combination of tazemetostat and Tecentriq (atezolizumab) for the treatment of relapsed/refractory diffuse large B-cell lymphoma ... Seeking Alpha, 2 days ago
Epizyme, Genentech to Evaluate Drug Combo in NHL - Contract Pharma, 2 days ago
Genentech, Epizyme to assess anti-cancer effects of tazemetostat/Tecentriq combination - Pharmaceutical Business Review, 2 days ago
Owen Dyer Montreal Roche's Genentech and OSI Pharmaceuticals will pay $67 million (£47m; €60m) to settle claims that they misled doctors by inflating cancer survival data with their non-small cell lung cancer drug erlotinib (Tarceva). The ...British Medical Journal, 1 week ago Drug Companies to Pay $67 Million for Exaggerating Claims, Misleading Doctors Before It's News, 2 weeks ago Genentech/OSI fined $67 million for skewing cancer-drug survival data BioPharma Dive, 2 weeks ago Drug companies pay $67 Million to resolve FCA allegations for cancer drug Pharmacist.com, 2 weeks ago
By Dayue Chen, PhD, Eli Lilly and Company, and Qi Chen, PhD, Genentech A Review of the Benefits and Challenges of Parvovirus Retentive Filters Virus removal using retentive filters designed to provide effective and consistent clearance of ...Bioresearch Online, 1 week ago
Contents Introduction Injectible, Sustained Drug Delivery for Biopharmceuticals Other Drug Delivery Interests Introduction (Back to Top) On April 15, Genentech Inc. (San Francisco) and Alkermes Inc. (Cambridge, MA) announced a two-year ...Pharmaceutical Online, 1 week ago
Thomas Perkins' Genentech investment is widely considered to have helped jump-start Silicon Valley's biotech industry. Thomas Perkins, one of the founding fathers of Silicon Valley, died this week at age 84 at his home in Belvedere, California, ...IT Web, 2 weeks ago ROCHE : Silicon Valley pioneer Thomas Perkins dies 4 Traders, 2 weeks ago
In a phase II study, IMvigor 210, atezolizumab (Tecentriq; Genentech, a member of the Roche Group)shrank tumors ( objective response rate , ORR) in 24% (n=28) of people with locally advanced or metastatic urothelial carcinoma (mUC) who have not ...Onco'Zine, 1 week ago Genentech's cancer immunotherapy TECENTRIQ shrank tumors in people with previously untreated advanced bladder cancer Seeking Alpha, 2 weeks ago Roche : Genentechs Cancer Immunotherapy TECENTRIQ (Atezolizumab) Shrank Tumors in People with Previously Untreated Advanced Bladder Cancer 4 Traders, 2 weeks ago ASCO2016: Genentech's TECENTRIQ Shrank Tumors in People with Previously Untreated Advanced Bladder Cancer BioSpace, 2 weeks ago
Phase III Study Shows Genentech's Actemra® tocilizumab Maintained Steroid-Free Remission in People With Giant Cell Arteritis GCA
By a News Reporter-Staff News Editor at Clinical Trials Week -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced positive results from the Phase III study known as GiACTA, which evaluated Actemra® (tocilizumab) in ...4 Traders, 1 week ago Genentech's Arthritis Med Actemra Successful In Late-Stage Study in Rare Artery Inflammation BioSpace, 2 weeks ago BRIEF-Genentech says phase III study shows Actemra maintained steroid-free remission in people with giant cell arteritis Reuters UK, 2 weeks ago Roche : Phase III Study Shows Genentech's Actemra (tocilizumab) Maintained Steroid-Free Remission in People with Giant Cell Arteritis (GCA) 4 Traders, 2 weeks ago
) - The HDA Research Foundation (formerly the Center for Healthcare Supply Chain Research), Genentech Inc., a member of the Roche Group, and Mylan Inc., honored Henry Dale Smith, Jr., of H. D. Smith Holding Company with the 2016 Nexus Award for ...Sys-Con Media, 1 week ago H.D. Smith Jr. honored with Nexus Award Chain Drug Review, 1 week ago
Data on Age-Related Macular Degeneration Reported by Researchers at Genentech, Inc. (Age-related macular degeneration: Complement in action)
By a News Reporter-Staff News Editor at Genomics & Genetics Weekly -- Data detailed on Eye Diseases and Conditions have been presented. According to news originating from San Francisco, California, by NewsRx correspondents, research stated, "The ...Equities.com, 1 day ago AACR Issues RFP for Cancer Research on the HER Family Pathway Philanthropy News Digest, 6 days ago Market Research on Global Non Small Cell Lung Cancer Therapeutics Consumption 2016 MyNewsDesk, 10 hours ago Detailed Study of the Global Skin Disease Treatment Technologies Consumption 2016 MyNewsDesk, 11 hours ago
New Findings from Genentech, Inc. in the Area of Nucleoproteins Reported (Cycling in the nucleus: regulation of RNA 30 processing and nuclear...
New Findings from Genentech, Inc. in the Area of Nucleoproteins Reported (Cycling in the nucleus: regulation of RNA 30 processing and nuclear organization of replication-dependent histone genes) By a News Reporter-Staff News Editor at Life Science ...Equities.com, 1 day ago New Subcellular Fractions Findings from Genentech, Inc. Reported (SNARE-Mediated Cholesterol Movement to Mitochondria Supports Steroidogenesis in... 4 Traders, 1 day ago Reports from Genentech, Inc. Add New Data to Findings in Acute Lung Injury (Innate-like function of memory T-h 17 cells for enhancing... 4 Traders, 1 week ago New Cytokines Study Findings Have Been Reported by Researchers at Genentech, Inc. [Fragment Molecular Orbital Method Applied to Lead Optimization of... 4 Traders, 2 weeks ago
on your WebpageAdd Widget >Get your members hooked!